During the past decade, Covance Clinical Research Unit Inc. conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 10 clinical trials were completed, i.e. on average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Covance Clinical Research Unit Inc." #1 sponsor was "Alexza Pharmaceuticals, Inc." with 5 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "CTI BioPharma" with 3 trials sponsored, "Virobay Inc." with 3 trials sponsored and "ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Covance Clinical Research Unit Inc." #1 collaborator was "Covance" with 2 trials as a collaborator, "Chroma Therapeutics" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "LEO Pharma" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Covance Clinical Research Unit Inc." are "Healthy" (13 trials), "Healthy Subjects" (2 trials), "Healthy Volunteers" (2 trials), "Arthritis" (1 trials) and "Cardiodynamics" (1 trials). Many other conditions were trialed in "Covance Clinical Research Unit Inc." in a lesser frequency.

Most popular intervention types in "Covance Clinical Research Unit Inc." are "Drug" (26 trials), "Other" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Inhaled placebo" (3 trials), "Oral moxifloxacin" (2 trials), "Oral placebo" (2 trials) and "VBY-036" (2 trials). Other intervention names were less common.

The vast majority of trials in "Covance Clinical Research Unit Inc." are 24 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Covance Clinical Research Unit Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Covance Clinical Research Unit Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Covance Clinical Research Unit Inc., 25 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".